001     275837
005     20250119000338.0
024 7 _ |a 10.1038/s41593-024-01814-0
|2 doi
024 7 _ |a pmid:39627589
|2 pmid
024 7 _ |a 1097-6256
|2 ISSN
024 7 _ |a 1546-1726
|2 ISSN
024 7 _ |a altmetric:171492556
|2 altmetric
037 _ _ |a DZNE-2025-00072
041 _ _ |a English
082 _ _ |a 610
100 1 _ |a Colonna, Marco
|0 0000-0001-5222-4987
|b 0
245 _ _ |a Implementation and validation of single-cell genomics experiments in neuroscience.
260 _ _ |a New York, NY
|c 2024
|b Nature America
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1736775085_27320
|2 PUB:(DE-HGF)
|x Review Article
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
520 _ _ |a Single-cell or single-nucleus transcriptomics is a powerful tool for identifying cell types and cell states. However, hypotheses derived from these assays, including gene expression information, require validation, and their functional relevance needs to be established. The choice of validation depends on numerous factors. Here, we present types of orthogonal and functional validation experiment to strengthen preliminary findings obtained using single-cell and single-nucleus transcriptomics as well as the challenges and limitations of these approaches.
536 _ _ |a 351 - Brain Function (POF4-351)
|0 G:(DE-HGF)POF4-351
|c POF4-351
|f POF IV
|x 0
588 _ _ |a Dataset connected to CrossRef, PubMed, , Journals: pub.dzne.de
650 _ 2 |a Single-Cell Analysis: methods
|2 MeSH
650 _ 2 |a Neurosciences: methods
|2 MeSH
650 _ 2 |a Animals
|2 MeSH
650 _ 2 |a Genomics: methods
|2 MeSH
650 _ 2 |a Humans
|2 MeSH
650 _ 2 |a Transcriptome
|2 MeSH
650 _ 2 |a Gene Expression Profiling: methods
|2 MeSH
700 1 _ |a Konopka, Genevieve
|0 0000-0002-3363-7302
|b 1
700 1 _ |a Liddelow, Shane A
|0 0000-0002-0840-1437
|b 2
700 1 _ |a Nowakowski, Tomasz
|0 0000-0003-2345-4964
|b 3
700 1 _ |a Awatramani, Rajeshwar
|0 0000-0002-0713-2140
|b 4
700 1 _ |a Bateup, Helen S
|0 0000-0002-0135-0972
|b 5
700 1 _ |a Cadwell, Cathryn R
|0 0000-0003-1963-8285
|b 6
700 1 _ |a Caglayan, Emre
|0 0000-0001-5340-8614
|b 7
700 1 _ |a Chen, Jerry L
|0 0000-0002-7409-7859
|b 8
700 1 _ |a Gillis, Jesse
|0 0000-0002-0936-9774
|b 9
700 1 _ |a Kampmann, Martin
|0 0000-0002-3819-7019
|b 10
700 1 _ |a Krienen, Fenna
|0 0000-0002-1400-6820
|b 11
700 1 _ |a Marsh, Samuel E
|0 0000-0002-3012-6945
|b 12
700 1 _ |a Monje, Michelle
|0 0000-0002-3547-237X
|b 13
700 1 _ |a O'Dea, Michael R
|0 0000-0002-6135-7607
|b 14
700 1 _ |a Patani, Rickie
|0 0000-0002-3825-7675
|b 15
700 1 _ |a Pollen, Alex A
|0 0000-0003-3263-8634
|b 16
700 1 _ |a Quintana, Francisco J
|0 0000-0001-8156-0736
|b 17
700 1 _ |a Scavuzzo, Marissa
|b 18
700 1 _ |a Schmitz, Matthew
|b 19
700 1 _ |a Sloan, Steven A
|0 0000-0001-7769-7684
|b 20
700 1 _ |a Tesar, Paul J
|0 0000-0003-1532-3155
|b 21
700 1 _ |a Tollkuhn, Jessica
|0 0000-0001-5991-7620
|b 22
700 1 _ |a Tosches, Maria Antonietta
|0 0000-0001-6338-9357
|b 23
700 1 _ |a Urbanek, Madeleine E
|b 24
700 1 _ |a Werner, Jonathan M
|0 0000-0001-9248-6420
|b 25
700 1 _ |a Bayraktar, Omer A
|0 0000-0001-6055-277X
|b 26
700 1 _ |a Gokce, Ozgun
|0 P:(DE-2719)9002754
|b 27
700 1 _ |a Habib, Naomi
|0 0000-0002-6049-2487
|b 28
773 _ _ |a 10.1038/s41593-024-01814-0
|g Vol. 27, no. 12, p. 2310 - 2325
|0 PERI:(DE-600)1494955-6
|n 12
|p 2310 - 2325
|t Nature neuroscience
|v 27
|y 2024
|x 1097-6256
856 4 _ |u https://pub.dzne.de/record/275837/files/DZNE-2025-00072_Restricted.pdf
856 4 _ |u https://pub.dzne.de/record/275837/files/DZNE-2025-00072_Restricted.pdf?subformat=pdfa
|x pdfa
909 C O |o oai:pub.dzne.de:275837
|p VDB
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 27
|6 P:(DE-2719)9002754
913 1 _ |a DE-HGF
|b Gesundheit
|l Neurodegenerative Diseases
|1 G:(DE-HGF)POF4-350
|0 G:(DE-HGF)POF4-351
|3 G:(DE-HGF)POF4
|2 G:(DE-HGF)POF4-300
|4 G:(DE-HGF)POF
|v Brain Function
|x 0
915 _ _ |a Nationallizenz
|0 StatID:(DE-HGF)0420
|2 StatID
|d 2025-01-07
|w ger
915 _ _ |a DEAL Nature
|0 StatID:(DE-HGF)3003
|2 StatID
|d 2025-01-07
|w ger
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
|d 2025-01-07
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
|d 2025-01-07
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Clarivate Analytics Master Journal List
|d 2025-01-07
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1050
|2 StatID
|b BIOSIS Previews
|d 2025-01-07
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0160
|2 StatID
|b Essential Science Indicators
|d 2025-01-07
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1030
|2 StatID
|b Current Contents - Life Sciences
|d 2025-01-07
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1190
|2 StatID
|b Biological Abstracts
|d 2025-01-07
915 _ _ |a WoS
|0 StatID:(DE-HGF)0113
|2 StatID
|b Science Citation Index Expanded
|d 2025-01-07
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
|d 2025-01-07
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b NAT NEUROSCI : 2022
|d 2025-01-07
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0600
|2 StatID
|b Ebsco Academic Search
|d 2025-01-07
915 _ _ |a Peer Review
|0 StatID:(DE-HGF)0030
|2 StatID
|b ASC
|d 2025-01-07
915 _ _ |a IF >= 25
|0 StatID:(DE-HGF)9925
|2 StatID
|b NAT NEUROSCI : 2022
|d 2025-01-07
920 1 _ |0 I:(DE-2719)1013041
|k AG Gokce
|l Spatial Dynamics of Neurodegeneration
|x 0
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a I:(DE-2719)1013041
980 _ _ |a UNRESTRICTED


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21